Sector valuations Merck KGaA

Equities

Market Closed - Xetra Other stock markets 16:49:37 12/12/2025 GMT			After hours 18:06:54
118.35 ^EUR	-0.42%		118.05	-0.25%

12-11	Merck KGaA's SpringWorks Gets UK Clearance for Plexiform Neurofibromas Therapy	MT
12-11	UK's MHRA approves mirdametinib to treat plexiform neurofibromas	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
MERCK KGAA	18.1x	1.62x	6.04x	2.83x	9.92x	15.45x	1.93%	60.86B
KYOWA KIRIN CO., LTD.	23.87x	1.51x	-3.76x	2.31x	10.28x	13.81x	2.37%	8.52B
HALOZYME THERAPEUTICS, INC.	11.41x	10.2x	0.2x	6.04x	9.19x	9.93x	-	7.28B
SK BIOPHARMACEUTICALS CO., LTD.	59.71x	14.71x	-2.29x	14.52x	44.44x	47.88x	-.--%	7.22B
YUHAN CORPORATION	71.56x	4.21x	1x	3.82x	43.63x	67.65x	0.43%	5.89B
INDIVIOR PLC	20.34x	-223.69x	-0.03x	3.68x	10.63x	11.07x	-.--%	4.47B
BETTA PHARMACEUTICALS CO., LTD.	35.47x	3.29x	0.86x	6.02x	19.85x	33.93x	0.75%	2.87B
SUPERNUS PHARMACEUTICALS, INC.	-60.14x	-	0.38x	-	-	-	-	2.67B
OSCOTEC INC.	268.61x	19.41x	0.31x	42.49x	175.05x	198.92x	-	1.56B
KISSEI PHARMACEUTICAL CO., LTD.	17.2x	0.93x	-6.15x	-	-	-	2.62%	1.22B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	13.53x	1.86x	0.09x	-	-	-	0.96%	1.16B
HK INNO.N CORPORATION	35.09x	1.27x	0.69x	2.09x	18.51x	27.27x	-	1B
Average	42.90x	-14.97x	-0.22x	9.31x	37.94x	47.32x	1.13%	8.73B
Weighted average by Cap.	26.39x	-6.26x	3.09x	4.67x	17.38x	23.66x	1.59%